Table 1.
Demographic Profile and Baseline Clinical Parameters of Participants (N = 78).a
| Variable | Intervention (n = 40) | Control (n = 38) | P Value |
|---|---|---|---|
| Age, y | 52.5 (17.1) | 58.6 (16.2) | .11 |
| Female, n (%) | 21 (51.2) | 17 (44.7) | .56 |
| Race, n (%) | |||
| African American | 10 (25) | 11 (29) | |
| Caucasian | 22 (55) | 18 (47) | |
| Hispanic | 8 (20) | 9 (24) | |
| Height, cm | 170.1 (10.5) | 170.7 (10.1) | .81 |
| Weight, kg | 86.3 (27.6) | 88.6 (27.2) | .71 |
| Body mass index, kg/m2 | 29.8 (9.3) | 30.1 (8.9) | .89 |
| BMI ≥30, n(%) | 18 (45) | 18 (47) | .83 |
| SGA category, n (%) | .15 | ||
| Normal | 27 (65.8) | 23 (60.5) | |
| Moderate | 11 (26.8) | 15 (39.5) | |
| Severe | 3 (7.3) | 0 | |
| Baseline SOFA | 9.3 (3.8) | 9.4 (3.4) | .97 |
| APACHE II | 23.4 (9.3) | 27.7 (7.9) | .03 |
| PaO2:FiO2, ratio | 195 (105) | 183 (122) | .69 |
| PaO2:FiO2, ratio ≤200, n (%) | 23 (58) | 21 (55) | .84 |
| CRP, mg/dL | 102.2 (92.2) | 131.2 (92) | .20 |
| White blood cell count, cells × 109/L | 13.3 (12.2) | 11.1 (6.2) | .34 |
| Glucose, mg/dL | 154 (48.9) | 150.9 (55.1) | .78 |
APACHE II, Acute Physiology and Chronic Health Evaluation; BMI, body mass index; CRP, C-reactive protein; SGA, Subjective Global Assessment; SOFA, Sequential Organ Failure Assessment:
a
Values are means (standard deviations) unless otherwise indicated.